MarketInOut Stock Screener Log In | Sign Up

Jupiter Neurosciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/29/2026 16:00
Jupiter Neurosciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3.48 mln
Float0.88 mln
Earnings Date11/13/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

4 / 100
Severely lagging

Pre-Tax Margin

-14,220%
Severely loss-making

ROE

-1,889
Deeply negative

Altman Z-Score

-22.52
Deeply distressed

ROA

-233
Deeply negative

Business Description

Jupiter Neurosciences is a pharmaceutical company based in Jupiter, Florida, focused on developing treatments for brain and nervous system diseases using a compound called resveratrol. The company currently has five drug candidates in Phase II clinical trials, targeting conditions such as Friedreich's Ataxia, early Alzheimer's disease, Parkinson's disease, and two other rare neurological disorders. Beyond prescription treatments, Jupiter Neurosciences also works with partners to create consumer health products aimed at healthy aging and longevity.

Key Fundamentals

EPS-18.94
ROE-1,889
RPS0.13
ROIC-199
ROA-233
Interest Cover-47.42
EBITDA, mln-8.93
EV / EBITDA-0.20
EV / EBIT-0.20
Revenue, mln0.06
EV / Revenue26.85

Quote Details

Last 2.37
Change -0.13 (-5.2%)
Open 2.56
Volume 7,165
Turnover 16,981
Average Volume 65,460

Financial Ratios

Pre-Tax Profit Margin-14,220
Current Ratio0.66
Price / Sales18.77

Financial Strength

Altman Z-Score-22.52
Piotroski F-Score 4 / 9
Short Ratio0.55
Short % of Float3.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.14% 8 / 100   
1 Month -2.87% 40 / 100   
2 Months -73.87% 2 / 100   
6 Months -91.67% 2 / 100   
1 Year -98.14% 2 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog